Prof. Dr. KADİR DEMİR

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.11, ss.945-954, 2022 (SCI-Expanded)

24. SINGLE CENTER EXPERIENCE OF WILSON DISEASE

Demir K., Ormeci A. C., Cavus B., Akyuz F., Besisik F., Kaymakoglu S.

HEPATOLOGY , cilt.76, 2022 (SCI-Expanded)

25. Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis

Telli P., Ozturk N. B., Hakan M. T., Cavus B., Ormeci A. C., Yakut A., et al.

HEPATOLOGY FORUM , cilt.3, sa.3, ss.77-81, 2022 (ESCI) Sürdürülebilir Kalkınma

26. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center

Evirgen S., Iliaz R., Akyuz F., Cavus B., Gokturk S., Ormeci A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.6, ss.463-469, 2022 (SCI-Expanded)

27. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?

İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.

Journal of Enterocolitis , cilt.1, ss.12-16, 2022 (Hakemli Dergi)

28. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Cavus B., Akyuz F., Iliaz R., Atasoy A., Akyuz U., Demir K., et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY , cilt.36, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

29. EVALUATION OF HELICOBACTER PYLORI FREQUENCY AND GASTRIC ANTRUM PATHOLOGY FINDINGS IN PATIENTS WITH PORTAL HYPERTENSION

Cavus B., Ormeci A., Evirgen S., Iliaz R., Atasoy A., Yegen G., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.85, sa.2, ss.211-215, 2022 (ESCI, TRDizin)

30. Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study

BAKKALOĞLU O. K., Yildirim O., Cavus B., Evirgen S., Gokturk S., Ormeci A., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.66, sa.1, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Prevalence and Association of Restless Leg Syndrome, Depression and Anxiety in Patients With Inflammatory Bowel Disease

Iliaz R., Ozturk N. B., Kilicarslan A. F., Akas R., Guzey D. Y., Senel E., et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.116, 2021 (SCI-Expanded)

32. Neurological features and outcomes of Wilson's disease: a single-center experience.

Samanci B., Sahin E., Bilgic B., Tufekcioglu Z., Gurvit H., Demir M. E., et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology , cilt.42, sa.9, ss.3829-3834, 2021 (SCI-Expanded, Scopus)

33. The development of extraintestinal manifestation and related risk factors in Crohn's patients

Kayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.190, sa.2, ss.597-604, 2021 (SCI-Expanded)

34. Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report

SOYTÜRK M., Bengi G., OĞUZ D., Kalkan I. H., YALNIZ M., TAHTACI M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.31, 2020 (SCI-Expanded)

35. MHC Class I related chain A (MICA), Human Leukocyte Antigen (HLA)-DRB1, HLA-DQB1 genotypes in Turkish patients with ulcerative colitis

Cinar Ç., Demir K., Temurhan S., Akyuz F., Pinarbasi B., Oguz F. S.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.45, sa.5, ss.587-592, 2020 (SCI-Expanded)

36. Strain and strain rate echocardiography variables in adult Wilson's disease patients: A speckle tracking echocardiography study

Cagan S., Gurbuz A. S., Ozturk S., Demir K.

JOURNAL OF CLINICAL ULTRASOUND , cilt.48, sa.6, ss.324-329, 2020 (SCI-Expanded)

37. The effect of propofol on frontal QRS-T angle in patients undergoing elective colonoscopy procedure

Tascanov M. B., TANRIVERDİ Z., GÜNGÖREN F., BEŞLİ F., YEŞİLAY A. B., Altiparmak H. I., et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.45, sa.1, ss.185-190, 2020 (SCI-Expanded)

38. Risk factors associated with progression to intestinal complications of Crohn disease

Kayar Y., Baran B., Ormeci A., Akyuz F., Demir K., Besisik F., et al.

CHINESE MEDICAL JOURNAL , cilt.132, sa.20, ss.2423-2429, 2019 (SCI-Expanded)

39. Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis

Iliaz R., Yuce T., Torun S., Cavus B., Gulluoglu M., Bozaci M., et al.

European journal of gastroenterology & hepatology , cilt.31, sa.10, ss.1247-1249, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

40. Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?

Akyuz F., Cavus B., Pinarbasi B., Bozaci M., Baran B., Akyuz U., et al.

Annals of Hepatology , cilt.18, sa.4, ss.585-589, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz F., Cavus B., Iliaz R., Soyer O. M., Ormeci A., Evirgen S., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.31, sa.7, ss.777-780, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

42. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers

Iliaz R., Ozpolat T., Baran B., Demir K., Kaymakoglu S., Besisik F., et al.

European Journal of Gastroenterology and Hepatology , cilt.30, sa.7, ss.786-791, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

43. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Evirgen S., et al.

WORLD JOURNAL OF HEPATOLOGY , cilt.10, sa.1, ss.51-61, 2018 (ESCI)

44. QTc nterval is prolonged in Wilson's disease with neurologic nvolvement

Ozturk S., Gurbuz A. S., Efe S. C., Iliaz R., Banzragch M., Demir K.

ACTA CLINICA BELGICA , cilt.73, sa.5, ss.328-332, 2018 (SCI-Expanded)

45. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines

Yurdaydin C., Tabak F., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

46. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines

Tabak F., Yurdaydin C., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.28, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

47. Belching in irritable bowel syndrome: An impedance study

Obekli T., Akyuz F., Akyuz U., Arici S., Iliaz R., Gokturk S., et al.

Journal of Neurogastroenterology and Motility , cilt.23, sa.3, ss.409-414, 2017 (SCI-Expanded, Scopus)

48. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts A retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Sahin D., Gokturk S., Evirgen S., et al.

MEDICINE , cilt.96, sa.1, 2017 (SCI-Expanded)

49. Analysis of hepatitis C virus NS5A region in patients with cirrhosis using an ultra-deep pyrosequencing method

Keskin F., Ciftci S., Akyuz F., Abaci N., Cakiris A., Akyuz U., et al.

Clinical Laboratory , cilt.63, sa.9, ss.1439-1445, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma

Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.

Arab Journal of Gastroenterology , cilt.17, sa.4, ss.164-167, 2016 (SCI-Expanded, Scopus)

51. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.52, ss.68-73, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

52. A Cross-sectional Study to Assess the Prevalence of Pancreatic Exocrine Insufficiency Among Diabetes Mellitus Patients in Turkey.

Demir K., Karaca C., AHISHALI E., Mestanzade M., Celik S., Gul N., et al.

Pancreas , cilt.45, sa.7, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Retention during capsule endoscopy: Is it a real problem in routine practice?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.44, sa.4, ss.968-975, 2016 (SCI-Expanded)

54. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?

Iliaz S., Iliaz R., Onur S. T., Arici S., Akyuz U., Karaca C., et al.

Respiratory Medicine , cilt.115, ss.20-25, 2016 (SCI-Expanded)

55. Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., Onel D., et al.

POSTGRADUATE MEDICINE , cilt.128, sa.4, ss.432-438, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

56. Effect of ejaculation on Serum Prostate-Specific Antigen concentration

Tarhan F., DEMİR K., Orcun A., Madenci O. C.

INTERNATIONAL BRAZ J UROL , cilt.42, sa.3, ss.472-478, 2016 (SCI-Expanded)

57. What is the impact of capsule endoscopy in the long term period?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY , cilt.8, sa.7, ss.344-348, 2016 (ESCI)

58. The effects of stress incontinence surgery on sexual function and life quality of women

Tuncer M., Tarhan F., Kafkasli A., DEMİR K., Yucetas U., Faydaci G., et al.

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA , cilt.88, sa.2, ss.106-110, 2016 (ESCI) Sürdürülebilir Kalkınma

59. Science and Mathematics Faculty Responses to a Policy-Based Initiative: Change Processes, Self-Efficacy Beliefs, and Department Culture

Ellett C. D., DEMİR K., Monsaas J.

INNOVATIVE HIGHER EDUCATION , cilt.40, sa.2, ss.127-141, 2015 (ESCI) Sürdürülebilir Kalkınma

60. Incidence of Secondary Renal Tumor, Surgical Treatment for Metastatic Malignancy to the Kidney: Clinical and Pathological Features

DEMİR K., Turk A., Selimoglu A., Aslan H., Celik O., Kafkasli A.

JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM , cilt.4, sa.3, ss.111-114, 2014 (ESCI)

61. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening

Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.49, sa.12, ss.1414-1418, 2014 (SCI-Expanded, Scopus)

62. Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. Endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer and dextranomer/hyaluronic acid in adults

Turk A., Selimoglu A., DEMİR K., Celik O., Saglam E., Tarhan F.

INTERNATIONAL BRAZ J UROL , cilt.40, sa.3, ss.379-383, 2014 (SCI-Expanded)

64. Effects of ejaculation on serum prostate-specific antigen levels

DEMİR K., Tarhan F., Orcun A., Aslan H., Turk A.

TURKISH JOURNAL OF UROLOGY , cilt.40, sa.1, ss.40-45, 2014 (ESCI)

65. Durability of sustained virologic response in chronic hepatitis C

UYANIKOĞLU A., Kaymakoglu S., Danalioglu A., Akyuz F., Ermis F., Pinarbasi B., et al.

Gut and Liver , cilt.7, sa.4, ss.458-461, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

66. Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors

Demir K., ORMECI A., Emrence Z., Gokturk S., Baran B., SOYER O. M., et al.

GASTROENTEROLOGY , cilt.144, sa.5, 2013 (SCI-Expanded)

67. Association of the MEFV Gene Variations With Inflammatory Bowel Disease in Turkey

Akyuz F., Besisik F., Ustek D., Ekmekci C., Uyar A., Pinarbasi B., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.3, 2013 (SCI-Expanded, Scopus)

68. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response

Karaca C., Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., et al.

ANTIVIRAL THERAPY , cilt.18, sa.4, ss.561-566, 2013 (SCI-Expanded)

69. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease

Pinarbasi B., Demir K., Oflaz H., Ahishali E., Akyuz F., Elitok A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, sa.6, ss.720-726, 2012 (SCI-Expanded, Scopus, TRDizin)

70. Gastrointestinal Dysfunctions After Spinal Cord Injury

Demir K.

TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION , cilt.58, ss.28-32, 2012 (SCI-Expanded)

71. Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: A case report

Baran B., Karaca C., Soyer O. M., Lacin S., Demir K., Besisik F., et al.

Clinics and Research in Hepatology and Gastroenterology , cilt.36, sa.4, 2012 (SCI-Expanded)

72. Anticoagulant therapy and Budd-Chiari syndrome: Is it successful?

Akyuz F., Cakaloglu Y., Pinarbasi B., Demir K., Akyuz U., Ozdil S., et al.

Hepato-Gastroenterology , cilt.58, ss.900-903, 2011 (SCI-Expanded)

73. Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: An esophageal impedance-pHmetry study

Ermis F., Akyuz F., Arici S., Uyanikoglu A., Yakar F., Pinarbasi B., et al.

Hepato-Gastroenterology , cilt.58, ss.1566-1573, 2011 (SCI-Expanded)

74. Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients?

Akyuz F., Pinarbasi B., Ermis F., Uyanikoglu A., Demir K., Ozdil S., et al.

Scandinavian Journal of Gastroenterology , cilt.45, sa.12, ss.1497-1502, 2010 (SCI-Expanded)

75. Electron microscopic findings in non-alcoholic fatty liver disease: Is there a difference between hepatosteatosis and steatohepatitis?

Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., et al.

Journal of Gastroenterology and Hepatology (Australia) , cilt.25, sa.3, ss.619-626, 2010 (SCI-Expanded)

76. The quality of life in hemodialysis patients with chronic hepatitis C virus infection

Akyuz F., Besisik F., Pinarbasi B., Demir K., Kaymakoglu S., Cakaloglu Y., et al.

Turkish Journal of Gastroenterology , cilt.20, sa.4, ss.243-246, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

77. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

Pinarbasi B., Kalymakoglu S., Matur Z., Akyuz F., Demir K., Besisik F., et al.

Journal of clinical gastroenterology , cilt.43, sa.2, ss.176-81, 2009 (SCI-Expanded)

78. Intestinal metaplasia in portal hypertensive gastropathy: A frequent pathology

Ibrisim D., Cevikbas U., Akyuz F., Poturoglu S., Ahishali E., Gulluoglu M., et al.

European Journal of Gastroenterology and Hepatology , cilt.20, sa.9, ss.874-880, 2008 (SCI-Expanded)

79. Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey

Cakaloglu Y., Akyuez F., Bozaci M., Ibrisim D., Pinarbasi B., Demir K., et al.

Turkish Journal of Gastroenterology , cilt.19, sa.2, ss.104-108, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

80. Rapidly progressive HCV cirrhosis in a hypogammaglobulinemic patient

Ermis F., Akyuez F., Demir K., Besisik F., Boztas G., Mungan Z.

Internal Medicine , cilt.47, sa.5, ss.415-417, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

81. MEFV gene mutations and inflammatory bowel disease: Is there any effect?

AKYÜZ F., Besisik F., Pinarbasi B., DEMİR K., KAYMAKOĞLU S., Ozdil S., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded)

82. Peptic ulcer disease: What did change in Turkey?

Yazici A., AKYÜZ F., İŞSEVER H., Pinarbasi B., DEMİR K., Ozdil S., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded)

83. HFE gene mutation, chronic liver disease, and iron overload in Turkey

YOENAL O., Hatirnaz O., AKYUEZ F., Oezbek U., Demir K., Kaymakoglu S., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.52, sa.11, ss.3298-3302, 2007 (SCI-Expanded)

84. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease

Akyuez F., Demir K., Oezdil S., Aksoy N., Poturoglu S., Ibrisim D., et al.

Digestive Diseases and Sciences , cilt.52, sa.9, ss.2359-2367, 2007 (SCI-Expanded)

85. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?

Demir K., Akyuz F., Ozdil S., Aksoy N., Kaymakoglu S., Poturoglu S., et al.

Annals of Hepatology , cilt.6, sa.2, ss.92-96, 2007 (Scopus) Sürdürülebilir Kalkınma

86. Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

Kaymakoglu S., Danalioglu A., Demir K., Karaca C., Akyuz F., Onel D., et al.

Digestive Diseases and Sciences , cilt.52, sa.3, ss.727-731, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

87. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy

Akyuz F., Kaymakoglu S., Demir K., Aksoy N., Karaca C., Danalioglu A., et al.

Acta Gastro-Enterologica Belgica , cilt.70, sa.1, ss.20-24, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

88. Tumor mimicking hepatic echinococcus alveolaris with portal vein thrombosis

Ermis F., Akyuz F., Ekmekci A., Dursun M., Gulluoglu M., Demir K.

INTERNAL MEDICINE , cilt.46, sa.19, ss.1675-1676, 2007 (SCI-Expanded)

89. PERNICIOUS ANEMIA ASSOCIATED WITH CRYPTOGENIC CIRRHOSIS

Cosan F., Pinarbasi B., Ibrisim D., GÜLLÜOĞLU M., DEMİR K., KAYMAKOĞLU S., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.70, sa.4, ss.107-110, 2007 (ESCI)

90. Effects of pyridoxine-HCL therapy on serum aminotransferase levels in haemodialysis patients

Demir K., Akyuez F., Aysuna N.

NEPHROLOGY , cilt.11, sa.5, ss.480, 2006 (SCI-Expanded)

91. Eating disorders and Celiac disease: A case report

Yucel B., OZBEY N., Demir K., POLAT A., Yager J.

INTERNATIONAL JOURNAL OF EATING DISORDERS , cilt.39, sa.6, ss.530-532, 2006 (SCI-Expanded, SSCI, Scopus)

92. Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels

Akyuz F., Polat N., Kaymakoglu S., Aksoy N., Demir K., Besisik F., et al.

World Journal of Gastroenterology , cilt.11, sa.45, ss.7188-7191, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

93. Merkel-cell carcinoma arising after liver transplantation: A case report

Esen B., PINARBASI B., Buyukbabani N., Baykal C., Cizmeci O., Demir K., et al.

TRANSPLANTATION PROCEEDINGS , cilt.37, sa.10, ss.4413-4415, 2005 (SCI-Expanded)

94. Sexual transmission of HCV between spouses

Tahan V., Karaca C., Yildirim B., Bozbaş A., Ozaras R., Demir K., et al.

American Journal of Gastroenterology , cilt.100, sa.4, ss.821-824, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

95. Is there any medical therapeutic option in hepatopulmonary syndrome? A case report

AKYÜZ F., KAYMAKOĞLU S., DEMİR K., Aksoy N., Adalet I., Ökten A.

European Journal of Internal Medicine , cilt.16, sa.2, ss.126-128, 2005 (Scopus)

96. Association Between Skin Tags and Colonic Polyps in Patients with Acromegaly

Kurtulmus N., YARMAN E. S., DEMİR K.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.9, sa.2, ss.45-47, 2005 (ESCI)

97. Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome

Diz-Kucukkaya R., Demir K., Yenerel M. N., Nalcaci M., Kaymakoglu S., Inanc M.

HAEMATOLOGIA , cilt.32, sa.1, ss.73-77, 2002 (SCI-Expanded, Scopus)

98. Assay of Mycobacterium tuberculosis in biopsy specimens taken from hepatic granuloma patients using polymerase chain reaction method

Tuncer İ., KÖKSALAN O. K., DEMİR K., Dinçer D., TÜRKOĞLU S., KAYMAKOĞLU S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.12, sa.3, ss.189-195, 2001 (Scopus) Sürdürülebilir Kalkınma

99. Miconazole induced acute hepatitis and sexual intercourse!

Beşişik F., Dinçer D., DEMİR K., KAYMAKOĞLU S., Çakalǒglu Y., Çevikbaş U., et al.

Turkish Journal of Gastroenterology , cilt.12, sa.1, ss.59-63, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

100. İrritabl barsak sendromu ve diabetes mellitusta aleksitiminin değerlendirilmesi

Yücel B., Turgay M., Gürel Y., Demir K., Yılmazer Alçalar A. N., Özkan S.

İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası , cilt.61, sa.1, ss.63-68, 1998 (Hakemli Dergi) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 49

1. HBsAg seroclearance in chronic hepatitis B is protective against hepatocellular carcinoma and decompensation

İstemihan Z., Kemeç G., Çetin O., İnan N. Y., Kaya B., Dağcı G., et al.

EASL Liver Cancer Summit 2026, Edinburgh, İngiltere, 22 - 24 Ocak 2026, ss.163, (Özet Bildiri)

2. Doğal Dil İşleme Tabanlı Kolon Temizliği Sınıflandırması ve Adenom Saptama Oranı ile İlişkisi

Ağargün B. F., Genç Uluçeçen S., Dağcı G., Yağlı M. A., Gurbanov A., Telli P., et al.

42. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 30 Kasım 2025, ss.128-131, (Tam Metin Bildiri)

3. Sirotik Hastalarda Kanamanın Gözden Kaçan Nedenleri : Portal Hipertansif Gastropati ve Gastrik Antral Vasküler Ektazi

Dağcı G., Sarıca A., Yağlı M. A., Akyüz F., Demir K., Kaymakoğlu S.

16.Ulusal Hepatoloji Kongresi , Ankara, Türkiye, 15 - 18 Mayıs 2025, ss.18, (Özet Bildiri)

4. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good

İstemihan Z., Kemeç G., Cebeci T., Çetin O., Genç Uluçeçen S., Rüstemzade A., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.803, (Özet Bildiri)

5. The relationship between spleen stiffness and portal hypertension liver transplant patients

Nurıyev K., İstemihan Z., Telli P., Qurbanov A., Yağlı M. A., Dağcı G., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.377-378, (Özet Bildiri)

6. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease

İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., Nurıyev K., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.551, (Özet Bildiri)

7. Clinical characteristics of patients with hereditary hemorrhagic telangiectasia: Real-life data, single-center experience

İstemihan Z., Bardak A. E., Nurıyev K., Rüstemzade A., Genç Uluçeçen S., Çavuş B., et al.

ESGE Days 2024, Berlin, Almanya, 25 - 27 Nisan 2024, ss.297, (Özet Bildiri)

8. Wilson Hastalığında Aile İçi Genetik Taramanın Kliniğe Önemli Katkıları

Şahin A., ÇİFCİBAŞI ÖRMECİ A., SUER İ., DEMİR K., KALAYCI T., ÇEFLE K., et al.

40. Ulusal Gastroenteroloji Haftası ve 11. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 21 - 26 Kasım 2023, (Özet Bildiri)

9. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi

Küçükkaya S., Çaklovica Küçükkaya İ., Çavuş B., Safran N., Önel M., Kırkoyun Uysal H., et al.

7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Türkiye, 1 - 05 Kasım 2023, ss.635, (Özet Bildiri)

10. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?

ÇOŞKUN A., Ormeci A. C., ÇAVUŞ B., ŞENKAL İ. V., KARAPINAR E., POYANLI A., et al.

Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)

11. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?

Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.

Digestive Disease Week 2023, Washington, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, ss.774, (Özet Bildiri)

12. WHAT ARE THE PREDICTORS OF SPLEEN STIFFNESS MEASUREMENT FAILURE BY TRANSIENT ELASTOGRAPHY?

Agargun B. F., Senkal V. I., Rustamzade A., Nuriyev K., Istemihan Z., Imanov Z., et al.

Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, (Özet Bildiri)

13. Fonksiyonel Dispepsili Hastalarda Pankreas Enzim Yetersizliğinin Etiyolojideki Yeri

Kemik F., Ceylan G., Aydın A. F., Demir K.

XXIII. ULUSAL KLİNİK BİYOKİMYA KONGRESİ, Antalya, Türkiye, 27 - 30 Nisan 2023, ss.150, (Özet Bildiri)

14. Tedavi naif ve deneyimli Kronik Hepatit B hastalarında tenofovir alafenamidin gerçek yaşam verileri: daha fazla etki, daha az yan etki

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 22 - 27 Kasım 2022, ss.1159-1162, (Özet Bildiri)

15. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

AASLD Liver Meeting , District Of Columbia, Amerika Birleşik Devletleri, 4 - 08 Kasım 2022, cilt.76, ss.299, (Özet Bildiri)

16. GAUCHER HASTALARINDA TRANSİENT ELASTOGRAFİ (FİBROSCAN®) YÖNTEMİ İLE KARACİĞER, DALAK SERTLİĞİ VE CAP SKORLARININ DEĞERLENDİRİLMESİ

Mutlu Ü., Çavuş B., Hacişahinoğulları H., Yenidünya Yalın G., Soyluk Selçukbiricik Ö., Gül N., et al.

43. TÜRKİYE ENDOKRİNOLOJİ VE METABOLİZMA HASTALIKLARI KONGRESİ 2022, Antalya, Türkiye, 18 - 22 Mayıs 2022, ss.187-188, (Özet Bildiri)

17. Gaucher hastalarında Transient Elastografi Fibroscan®) yöntemi ile karaciğer, dalak sertliği ve CAP skorlarının değerlendirilmesi

MUTLU Ü., ÇAVUŞ B., HACİŞAHİNOĞULLARI H., YENİDÜNYA YALIN G., SOYLUK SELÇUKBİRİCİK Ö., GÜL N., et al.

43. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Antalya, Türkiye, 18 - 22 Mayıs 2022, ss.187-188, (Özet Bildiri)

18. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

Çiftçi A. C., Konyaoğlu H., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., et al.

21. Çapa Gastroenteroloji Günleri, İstanbul, Türkiye, 31 Mart - 02 Nisan 2022, ss.70, (Tam Metin Bildiri)

19. Ön Segment Optik Koherans Tomografi (OCT), Wilson hastalığı tanısında Kayser Fleischer Halkası varlığını değerlendirmeki yeri - Ehil oftalmolog gerekliliğine son verecek mi?

Çifcibaşı Örmeci A., Bayraktar Ş., Işık A. O., İstemihan Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.218, (Özet Bildiri)

20. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.219, (Özet Bildiri) Sürdürülebilir Kalkınma

21. Karaciğer Transplantasyonunda Covid-19 Sıklığı Ve Risk Faktörleri

SEYİTHANOĞLU D., TELLİ P., BELOĞLU Y. N., YAKUT A., ŞENKAL İ. V., İMANOV Z., et al.

13. ULUSAL HEPATOLOJİ KONGRESİ, Türkiye, 28 - 30 Mayıs 2021, (Özet Bildiri)

22. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?

Kapar C., Cavus B., Atasoy A., Suleymanova V., Isik A., Karahan L., et al.

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Bariyatrik by-pass cerrahisi sonrası uzun dönemde geğirti artıyor mu?

AKYÜZ F., TELLİ P., nizam n., GÖKSOY B., ATASOY A., ÇAVUŞ B., et al.

7. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 29 Kasım - 01 Aralık 2019, ss.99, (Özet Bildiri)

24. Is belching increasing after bariatric by-pass surgery in the long term period?

AKYÜZ F., GÖKSOY B., TELLİ P., NİZAM N., ATASOY A., ÇAVUŞ B., et al.

United European Gastroenterology (UEG) Week 2019, İspanya, 19 - 23 Ekim 2019, cilt.7, ss.703, (Özet Bildiri)

25. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖĞÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Özet Bildiri)

26. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖGÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Tam Metin Bildiri)

27. Is It Sufficient Only to Request an Anti-HCV Test for the Performance of HCV Screening?

Deniz R., Karsli S., Ekinci O. B., Kalantarova I., Atasoy A., Onel M., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)

28. Clinical Impact of Endosonography in the Differantial Diagnosis of Indeterminate Biliary Strictures

Akyuz F., Deniz R., Karsli S., Akyuz U., Atasoy A., Demir K., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Kostarika, 9 - 13 Kasım 2018, cilt.68, (Özet Bildiri)

29. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Akyuz F., Iliaz R., Cavus B., Atasoy A., Akyuz U., Demir K., et al.

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66, (Özet Bildiri) Sürdürülebilir Kalkınma

30. Tens asitli siroz hastalarında intraabdominal hipertansiyonun prognoz üzerine etkisi

MUTLU Ü., ATASOY A., ILIAZ R., ÇAVUŞ B., AKYÜZ F., DEMİR K., et al.

11. Ulusal Hepatoloji Kongresi, Antalya, Türkiye, 17 - 21 Mayıs 2017, ss.31-32, (Özet Bildiri)

31. Vitamin D receptor gene polymorphisms may affect the interferon response in chronic hepatitis B patients

AKYÜZ F., UÇAR A. R., ÇİFTÇİ S., KESKİN F., ILIAZ R., ÇAVUŞ B., et al.

26th Annual Conference of APASL, Shanghai, Çin, 15 - 19 Şubat 2017, cilt.11, sa.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

32. Kronik hepatit C’li hastalar artık daha yaşlı ve daha ciddi karaciğer hastalığı ile kliniğe başvuruyor

ILIAZ R., YÜCE İNEL T., TORUN E. S., ÇAVUŞ B., GÜLLÜOĞLU M., Bozacı M., et al.

XIII. Ulusal Viral Hepatit Kongresi, Antalya, Türkiye, 17 - 20 Mart 2016, ss.18, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

33. Cyclosporine Therapy As a Rescue Treatment in Acute Severe Ulcerative Colitis: A Real Life-Data From a Tertiary Center

Evirgen S., Iliaz R., AKYÜZ F., ÇAVUŞ B., Pinarbasi B. S., Karaca C., et al.

46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 Mayıs 2015, cilt.148, (Özet Bildiri)

34. GRANÜLOMATÖZ ALANLAR İÇEREN İNTRAHEPATİK LENFOEPİTELYOMA BENZERİ KOLANJİOKARSİNOM OLGU SUNUMU

YEGEN G., BİLGİÇ A., ÖNDER S., DEMİR K., EKİZ F., DOĞAN İ. Ö., et al.

24. ULUSAL PATOLOJİ KONGRESİ, Trabzon, Türkiye, 19 - 23 Kasım 2014, (Özet Bildiri)

35. Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.

Gokturk S., Baran B., Ormeci A., Soyer O., Evirgen S., Ozden I., et al.

Joint International Congress of ILTS, ELITA and LICAGE, London, Kanada, 4 - 07 Haziran 2014, cilt.20, (Özet Bildiri)

36. The Course of Pregnancy in Wilson's Disease-One Center, 20 Years' Experience

DEMİR K., Soyer O. M., Karaca C., BEŞIŞIK S. F., KAYMAKOĞLU S., BEŞIŞIK S. F.

55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2014, cilt.146, (Özet Bildiri)

37. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

Ormeci A., Akyuz F., Baran B., Soyer O. M., Gokturk S., Karaca C., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

38. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

39. Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B

Akyuz F., Gokturk S., Baran B., Ormeci A., Soyer O. M., Evirgen S., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

40. Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Poyanli A., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)

41. Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection

Gokturk S., Basar R., Ucar A. R., Basgoze B. H., Altinkaynak M., Buyukballi P., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

42. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)

43. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

AKYÜZ F., Soyer O. M., Gokturk S., ÇİFCİBAŞI ÖRMECİ A., Evirgen S., Onder S. Y., et al.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, Amerika Birleşik Devletleri, 18 - 21 Mayıs 2013, cilt.144, (Özet Bildiri)

44. Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients

Baran B., Ozcan E., Oztop N., Cakmak R., Soyer O. M., Ormeci A., et al.

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri)

45. EVALUATION OF MICA, HLA-DRB1 AND HLA-DQB1 GENOTYPES IN PATIENTS WITH ULCERATIVE COLITIS

Kekik C., Pinarbasi B., Akyuz F., Oguz F., Demir K., Carin M. N.

Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, Birleşik Krallık, 31 Mayıs - 03 Haziran 2012, cilt.79, ss.577, (Özet Bildiri)

Kitaplar 1

1. Kronik Hepatit C hastalarında Diyabet Gelişiminde İnsülin Direncinin ve Otoimmünitenin Rolü

SALMAN S., TÜTÜNCÜ Y., DEMİR K., GÜLŞEN M., SELÇUKBİRİCİK F., GÜROL A. O., et al.

Türk Diyabet Yıllığı 2001 2002, , Editör, Türkiye Diyabet Vakfı ve Türk Diabet Cemiyeti tarafından hazırlanmıştır, İstanbul, ss.107-117, 2002 Sürdürülebilir Kalkınma

Bilirkişi Raporları 2

1. Bilirkişi Raporu

Kudat H., Demir K., Kılıçarslan Z., Alkan N., Çağatay A. A.

Düzce Üniversitesi, ss.2, Düzce, 2020

2. Bilirkişi Raporu

Akyüz F., Demir K., Kudat H.

İstanbul 18. Asliye Hukuk Mahkemesi 2014/4 Talimat , ss.3, İstanbul, 2014

Metrikler

Yayın

152

Yayın (WoS)

112

Yayın (Scopus)

Atıf (WoS)

648

H-İndeks (WoS)

Atıf (Scopus)

759

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler